DRUG WARS: Making it up as they go
If you worry that drugs cause enough serious adverse reactions and side-effects even after passing through a supposed draconian approval process, you’ll be even more concerned about a subtle lobbying that could lead to a relaxation of the licensing...
Oncologists and cancer researchers in the UK are very angry. The object of their ire is the ‘faceless bureaucracy’ of the European Union in Brussels which, they say, is holding back research and new therapies into the disease.